% | $
Quotes you view appear here for quick access.

Chembio Diagnostics, Inc. Message Board

  • sonomaca sonomaca Mar 14, 2013 11:11 AM Flag

    No shares for institutions to buy

    The Roth thing must be a prelude to a secondary offering. Yet, it's inconceivable that it would be done at anything less than $7.50.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • What's the Roth thing?

      They would not issue shares (dilute the stock price) just for institutions. Also, that would be significant. Now, if an insider want's to sell shares (as with Alere) an institution may buy in a direct transaction. That's fine.

      No need for secondary unless they need to expand. They are cash flowing development. If they issue shares for development cash flow needs this could drop like a rock and threaten NASDAQ listing.

7.03-0.02(-0.28%)Apr 29 3:59 PMEDT